India News: NPPA committee faces conflict as industry reps reform pricing rules. Activists criticize the DoP's composition. Will the industry influence drug prici
Panel for drug price review expanded financialexpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from financialexpress.com Daily Mail and Mail on Sunday newspapers.
The government has expanded a committee to include more industry representation for reviewing drug and medical device pricing reforms. This move aims to ensure better availability of medicines and devices, while also providing incentives for industry growth and export sustainability. The committee will engage with industry experts and associations to evaluate pricing and availability issues. Ultimately, the government will make the final decisions, with the committee focusing on balancing pricing and availability of essential medicines and designing a price moderation framework for medical devices.
National News: India risks being edged out of patent waiver plan at WTO rashtranews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from rashtranews.com Daily Mail and Mail on Sunday newspapers.